Aperio Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Aperio Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,386	Closed	-$249K	–	2429
2019 Q4	$249K	Sell	2,386 -1,395	-37%	-$156K	﹤0.01%	2125
2019 Q3	$435K	Buy	3,781 +1,018	+37%	+$155K	﹤0.01%	1838
2019 Q2	$476K	Buy	2,763 +106	+4%	+$18.3K	﹤0.01%	1805
2019 Q1	$448K	Sell	2,657 -742	-22%	-$110K	﹤0.01%	1810
2018 Q4	$331K	Sell	3,399 -1,402	-29%	-$184K	﹤0.01%	1896
2018 Q3	$829K	Sell	4,801 -16	-0.3%	-$2.31K	﹤0.01%	1515
2018 Q2	$672K	Sell	4,817 -531	-10%	-$75.4K	﹤0.01%	1608
2018 Q1	$603K	Buy	5,348 +23	+0.4%	+$2.89K	﹤0.01%	1600
2017 Q4	$703K	Buy	5,325 +569	+12%	+$66.9K	﹤0.01%	1524
2017 Q3	$483K	Buy	4,756 +1,154	+32%	+$124K	﹤0.01%	1679
2017 Q2	$361K	Buy	3,602 +586	+19%	+$63.1K	﹤0.01%	1804
2017 Q1	$365K	Buy	+3,016	New	+$370K	﹤0.01%	1730

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Aperio Group's GWPH Position: Q1 2020 in Review

Aperio Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 2,386 shares — an estimated $249K sold.

Aperio Group first reported a position in GWPH in Q1 2017 and held it in 12 quarters. The position peaked at $829K in Q3 2018. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Aperio Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Aperio Group sold 2,386 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $249K.
Aperio Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 12 quarters.
Aperio Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $829K in Q3 2018.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.